MedTrace Logo

Study to Analyze the Aerobic Performance Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists

NCT06167395 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2024-05-17

No results posted yet for this study

Summary

Randomized, controlled, double-blind, double-blind clinical trial, with three parallel arms depending on the product consumed (experimental product dose 1 and dose 2 and placebo product) and single-center, to measure the efficacy of a sustained release beta alanine on the aerobic performance efficacy in recreational cyclist

Conditions

  • Beta Alanine Supplementation

Interventions

DIETARY_SUPPLEMENT

Beta Alanine high dose

Subjects should consume 4 intakes of 5 g of beta alanine every 3 hours each day.

DIETARY_SUPPLEMENT

Beta Alanine low dose

Subjects should consume 4 intakes of 2,5 g of beta alanine every 3 hours each day.

DIETARY_SUPPLEMENT

Control product

Subjects should consume 4 intakes of 2,5 g of wheat semolina every 3 hours each day.

Sponsors & Collaborators

  • Universidad Católica San Antonio de Murcia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-04
Primary Completion
2024-02-19
Completion
2024-03-29

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06167395 on ClinicalTrials.gov